Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Pain, Postoperative 7Neuralgia 5Breast Neoplasms 4Pain 3Neoplasms 2Head and Neck Neoplasms 2Chronic Pain 2Brain Neoplasms 2Agnosia 2Visceral Pain 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Seizures 1Pinealoma 1Persistent Postoperative Pain 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Mouth Neoplasms 1Meningioma 1Medulloblastoma 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Leiomyoma 1Inflammation 1Hot Flashes 1Gliosarcoma 1

Interventions

Cyclophosphamide 297Rituximab 272Etoposide 149Filgrastim 142fludarabine phosphate 120Cytarabine 109Vincristine 107Melphalan 102Radiotherapy 101Doxorubicin 97Peripheral Blood Stem Cell Transplantation 93Methotrexate 91fludarabine 86Prednisone 86Busulfan 86Tacrolimus 66Mycophenolic Acid 62Granulocyte Colony-Stimulating Factor 60Antilymphocyte Serum 58Dexamethasone 57Whole-Body Irradiation 55Carmustine 54Bortezomib 45Cyclosporine 44Lenalidomide 41Methylprednisolone 40sargramostim 39Bendamustine Hydrochloride 37ibritumomab tiuxetan 34Ifosfamide 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma × Pregabalin × Clear all
NCT03407430 2018-06-26

Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
11 enrolled 17 charts
BreastLymphoid

Breast Neoplasms, Lymphoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡